Skip to main contentSkip to navigationSkip to search

Analyst coverage

The following analysts follow the developments of Curasight on a regular basis.


Research (commissioned) initiated on 18 June 2021 (see press release here).
SEB's corporate page on Curasight is here.

HC Andersen Capital

Research (commissioned) initiated June 2021. Please visit

Follow Curasight’s progress by subscribing to news and press releases

Choose type

Thank you. You will get an e-mail message to activate your subscription.

Latest Press Releases

Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague

September 14, 2023
 | Regulatory

Curasight to present at HC Andersen Capital and at HC Andersen Life Science seminar

August 25, 2023
 | Regulatory

Interim Report January – June 2023

August 24, 2023
 | Regulatory